Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Multiple doses of BMS-204352 safe and well tolerated in acute stroke patients

Dec. 4, 2000

Antagonism of neuropeptide Y1 receptors protects against focal cerebral ischemia

Dec. 4, 2000

Neuroprotective effects demonstrated in vitro and in vivo for new caspase inhibitor

Dec. 4, 2000

NXY-059 to enter phase I trials as a potential treatment for acute stroke in Japan

Dec. 4, 2000

Selective NK3 receptor antagonists patented by Neurogen R&D team

Dec. 1, 2000

Dual 5-HT1A ligands/5-HT transporter inhibitors under study at AHP for depression

Dec. 1, 2000

Axonyx begins study of tolserine for memory enhancement

Dec. 1, 2000

(S)-(-)-AR-A008055, a new gabamimetic agent related to clomethiazole, exerts neuroprotective effect

Dec. 1, 2000

Phase I/IIa results for UK-279276 presented at World Stroke Congress; phase IIb trial begins

Dec. 1, 2000

Postischemic NS-7 reduces histological and neurological brain damage in rats

Dec. 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...